Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss
dc.contributor.author | Ates H. | |
dc.contributor.author | Andac K. | |
dc.contributor.author | Uretmen O. | |
dc.date.accessioned | 2019-10-27T00:27:08Z | |
dc.date.available | 2019-10-27T00:27:08Z | |
dc.date.issued | 1999 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Purpose: The aim of the study was to determine the medium term intraocular pressure (IOP) lowering effects and the potential complications of non-penetrating deep sclerectomy and collagen implant (DSCI) surgery in glaucoma patients. Patients and methods: 54 eyes of 52 patients with medically uncontrolled open angle glaucoma with advanced field loss underwent DSCI under topical anaesthesia. Follow-up period was 24 months. Results: The mean preoperative IOP was 24.7 ± 6.2 mmHg and decreased to 15.1 ± 4.0 mmHg at 24 months (p = 0.0068). During the follow-up period, 36 of 54 eyes (66%) received no topical antiglaucomatous medications. In 18 eyes, monotherapy with topical beta blockers (Betaxolol HCl) was added to the regimen. At last visit, only two patients (3.8%) had IOP greater than 18 mmHg. We did not detect any additional optic disc changes, visual field or visual acuity defects postoperatively. Detailed slit-lamp examination revealed no anterior segment complications regarding the probable complications of trabeculectomy. None of the patients developed surgery related cataract. As a complication, we diagnosed one case of self-limited, shallow choroidal detachment. Conclusion: DSCI appears to provide considerable medium term IOP decrease with few postoperative complications without deteriorating visual acuity. Owing to our medium term results, we believe that DSCI could be a valuable alternative to trabeculectomy especially in cases of advanced medically uncontrolled open angle glaucoma. | en_US |
dc.identifier.doi | 10.1023/A:1010745204480 | en_US |
dc.identifier.endpage | 128 | en_US |
dc.identifier.issn | 0165-5701 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 11456247 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 123 | en_US |
dc.identifier.uri | https://doi.org/10.1023/A:1010745204480 | |
dc.identifier.uri | https://hdl.handle.net/11454/23488 | |
dc.identifier.volume | 23 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | International Ophthalmology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Advanced visual field loss | en_US |
dc.subject | Collagen implant | en_US |
dc.subject | Deep-sclerectomy | en_US |
dc.subject | Glaucoma | en_US |
dc.subject | Surgery | en_US |
dc.title | Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss | en_US |
dc.type | Article | en_US |